WHO ICTRP trial
Study comparing two standard treatments as initial metastatic treatment among…
CTIS2024-513005-31-00 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2024-513005-31-00 |
|---|---|
| Public title | Study comparing two standard treatments as initial metastatic treatment among patients with visceral metastasis of ER+ HER2- breast cancer, high burden disease: chemotherapy and combination of hormonotherapy with abemaciclib. |
| Scientific title | AMBRE : Open-label, randomized, multicenter, phase III study, comparing standard chemotherapy to standard combination of endocrine therapy with Abemaciclib as initial Metastatic treatment among patients with visceral metastasis of ER+ HER2- BREast cancer, high burden disease. - UC-0140/1901 |
| Primary sponsor | Unicancer |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): Yes Therapeutic use - (Phase IV): No |
| Countries | France |
| Conditions | Patients with untreated metastatic Estrogen Receptor positive (ER+), Human Epidermal Growth Factor Receptor-2 negative (HER2-) breast cancer with visceral involvement MedDRA version: 27.0Level: LLTClassification code: 10027475Term… |
| Interventions | Product Name: PACLITAXEL, Product Code:SUB09583MIG, Pharmaceutical Form: CONCENTRATE FOR SOLUTION FOR INFUSION, Other descriptive name: , Strength: , Product Name: CAPECITABINE, Product Code:SUB12474MIG, Pharmaceutical Form: FILM COATED… |
| Registration date | Sep 8, 2024 |
| Target size | 180 |
| Secondary IDs | NCT04158362;2019-000260-14 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: